Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.51 |
| ▸ | CA2 | P00918 | 2/20 | 0.51 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.49 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.45 |
| ▸ | ITGB2 | P05107 | 4/20 | 0.44 |
| ▸ | ICAM1 | P05362 | 4/20 | 0.44 |
| ▸ | ITGAL | P20701 | 4/20 | 0.44 |
| ▸ | FNTA | P49354 | 4/20 | 0.42 |
| ▸ | FNTB | P49356 | 4/20 | 0.42 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.41 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.41 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.40 |
| ▸ | REN | P00797 | 1/20 | 0.40 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.39 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14883199 | 1.00 | CA1 (0.51) | CA1CA2SLC15A2AGTR2ITGB2 | |
| SCHEMBL16767779 | 0.77 | SLC15A2 (0.48) | CA1CA2SLC15A2ITGB2ICAM1 | |
| SCHEMBL26312334 | 0.74 | SLC15A2 (0.64) | SLC15A2REN | |
| SCHEMBL15942886 | 0.73 | CA1 (0.59) | CA1CA2AGTR2ITGB2ICAM1 | |
| SCHEMBL31056974 | 0.71 | REN (0.57) | FNTAFNTBPGGT1BREN | |
| SCHEMBL14667370 | 0.70 | CA1 (0.50) | CA1CA2AGTR2ITGB2ICAM1 | |
| SCHEMBL31056946 | 0.69 | FNTA (0.50) | ITGB2ICAM1ITGALFNTAFNTB | |
| SCHEMBL7292522 | 0.69 | CTSL (0.57) | AGTR2RENCAPN1 | |
| SCHEMBL4525493 | 0.69 | CA1 (0.72) | CA1CA2AGTR2ITGB2ICAM1 | |
| SCHEMBL14817971 | 0.69 | CA1 (0.56) | CA1CA2SLC15A2AGTR2ITGB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9086416-B2 | Removable saccharide-benzimidazole (BIM) tags and conjugates thereof via 1H-position of the benzimidazoles | ACADEMIA SINICA (TW) | 2015-07-21 | — | — | US | disclosed |
| US-20130102049-A1 | REMOVABLE SACCHARIDE-BENZIMIDAZOLE (BIM) TAGS AND CONJUGATES THEREOF VIA 1H-POSITION OF THE BENZIMIDAZOLES | ACADEMIA SINICA (TW) | 2013-04-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130102049-A1 | REMOVABLE SACCHARIDE-BENZIMIDAZOLE (BIM) TAGS AND CONJUGATES THEREOF VIA 1H-POSITION OF THE BENZIMIDAZOLES | SORD, BTD, DERA | CA1 540/4885CA2 2193/4885SLC15A2 3167/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.